TP53 and diabetic kidney disease: We demonstrated that upon STZ-induced DKD, p53 was only decreased in FynKO mice, along with Tgm2 protein expression, therefore providing the first evidence of a molecular basis for the role of the Fyn–Tgm2–p53 axis in the development of DKD.